PD-184161

CAS : 212631-67-9

Ref. TR-P218100

Informations sur le produit

• Nom: PD-184161
• Synonymes: 5-Bromo-2-[(2-chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluorobenzamide

Description

Applications PD-184161 is a novel mitogen-activated protein kinase kinase (MEK) inhibitor shown to exhibit antitumor effects and suppress MEK-extracellular signal-related kinase signaling activity and cell proliferation in human hepatocellular carcinoma cells and in human hepatocellular carcinoma xenografts.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Yip-Schneider, M.T. et al.: J. Pharmacol. Exp. Therap., 329, 1063 (2009); Klein, P.J. et al.: Neoplasia, 8, 1 (2006); Yung, H.W. et al.: Biochem. Pharmacol., 68, 351 (2004);

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 557.5556
• Formule: C₁₇H₁₃BrClF₂IN₂O₂
• Couleur/Forme: Neat
• InChI: InChI=1S/C17H13BrClF2IN2O2/c18-11-6-10(17(25)24-26-7-8-1-2-8)16(15(21)14(11)20)23-13-4-3-9(22)5-12(13)19/h3-6,8,23H,1-2,7H2,(H,24,25)
• Code InChI: InChIKey=VJNZMSLGVUSPCF-UHFFFAOYSA-N
• SMILES: O=C(NOCC1CC1)c1cc(Br)c(F)c(F)c1Nc1ccc(I)cc1Cl